Acceleron Pharma Inc

Latest articles

16d
Business Wire
Acceleron Announces Closing of Underwriters’ Option to Purchase Additional SharesCAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ: XLRN), a lead
Business Wire / Posted 16 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ: XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today announced that it has issued 810,810... Read more
2 related articles

In this news